Home Search

COVID - search results

If you're not happy with the results, please do another search
Patient getting a shot

COVID-19 Immunity Strengthens over Time Between Vaccination and Infection

Immunity from COVID-19 appears to increase over time between vaccination and infection, and vice versa, according to a new study from OHSU.
Coronavirus particles, illustration - SARS-CoV-2 virus

Rare COVID-19 Vaccine Complication Linked to Circulating Spike Protein in Blood

A recent study has linked spike protein in the bloodstream with rare cases of myocarditis following vaccination with an mRNA COVID-19 vaccine.
Syringe with covid-19 coronavirus vaccine and medication tablets for symptoms.

Can COVID-19 Reboot Drug Repurposing?

It seems like a slam dunk. Why not repurpose already approved or well-studied drug candidates for conditions where treatments are desperately needed? Wouldn’t that...
William Haseltine

The Dawn of Next Generation COVID-19 Vaccines

Over time people will inevitably get tired of needing two or three booster shots a year. Vaccine uptake will dwindle and we will be back to square one. We are already seeing this happen, with only around 10% of the US population having opted to get the latest bivalent booster.
Intestinal villi. Small finger-like projections that extend into the lumen of the small intestine. Gut bacteria, flora, microbiome. 3d illustration.

COVID-19 Infection Disrupts Gut Microbiome

Research from Rutgers University shows that acute infection with COVID-19 leads to disruptions in the gut microbiome, which may at least partly explain gastrointestinal issues experienced by many patients during the acute and recovery phases of infection.
coronavirus as a globe

IL-26 Potential Biomarker for Acute COVID-19

The cytokine IL-26 may be a biomarker of acute COVID-19 according to a preliminary study by researchers at Karolinska Institute. It may also be a good new target for drug discovery.
image of lungs with SARS-CoV-2 particles on them to indicate infection and lung damage from COVID-19

Outcomes for Nasopharyngeal Cancer Improve after COVID-19 Vaccination

Nasopharyngeal cancer drugs worked better in patients who received the SinoVac vaccine than in unvaccinated patients.
coronavirus as a globe

COVID-19 Triggers Brain Inflammation Similar to Parkinson’s and Other Neurodegenerative Conditions

COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease and other neurodegenerative conditions, according to research led by University of Queensland (UQ), Australia.

How COVID-19 Forever Changed the In Vitro Diagnostics Marketplace

In this session of The State of Biotech, Larry Worden, principal and founder of IVD Logix, discusses how COVID put a spotlight on clinical lab testing and the IVD industry, how this focus impacted non-COVID testing, the trend toward at-home diagnostic testing, the rapid emergence and expansion of new companies and manufacturing capacity for diagnostic testing platforms, and the anticipated reemergence of traditional market dynamics.
Antibody proteins attacking coronavirus, illustration

Nanoparticles Plus mRNA as Basis for “Universal” COVID-19 Treatment

A new study has produced a proof of principle for a new “universal” means of treating COVID-19.  Using messenger RNA packaged in lipid nanoparticles, scientists showed in a mouse model that host cells can produce a “decoy” enzyme that binds to coronavirus spike proteins,


Inside Precision Medicine